Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
HERCESSI™ becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...
Fintel reports that on December 22, 2025, Citigroup maintained coverage of Strategy Inc - Preferred Stock (NasdaqGS:STRF) with a Buy recommendation. Analyst Price Forecast Suggests 213.83% Upside As ...
Fintel reports that on December 22, 2025, Citigroup maintained coverage of Strategy Inc - Preferred Stock (NasdaqGS:STRF) with a Buy recommendation. As of December 21, 2025, the average one-year price ...
Fintel reports that on December 8, 2025, Bernstein maintained coverage of Strategy Inc - Preferred Stock (NasdaqGS:STRF) with a Outperform recommendation. Analyst Price Forecast Suggests 193.43% ...
Strategy’s (MSTR) senior perpetual preferred stock, STRF, is increasingly standing out as the company’s most successful credit instrument since its launch in March. Trading at $110, STRF has risen 36% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results